Press Releases Archives - Page 22 of 103 - Lupin

BSE 2324.25 NSE 2324.50

indian flag icon

India

USA

great-britain flag icon

UK

south-africa flag icon

South Africa

australia flag icon

Australia

philippines flag icon

Philippines

germany flag icon

Germany

netherlands flag icon

Netherlands

mexico flag icon

Mexico

brazil flag icon

Brazil

canada flag icon

Canada

Switzerland flag icon

Switzerland

BSE 2324.25 NSE 2324.50

Lupin Receives Approval from U.S. FDA for Bromfenac Ophthalmic Solution, 0.09%

August 16, 2023

Lupin Receives Approval from U.S. FDA for Doxycycline Hyclate Delayed-Release Tablets USP

August 14, 2023

Lupin’s Mandideep Unit-2 Facility Completes U.S. FDA Inspection with No Observations

August 14, 2023

Lupin Receives Approval from U.S. FDA for Fluocinolone Acetonide Body Oil

Lupin Digital Health Launches first-of-its-kind Digital Heart Failure Clinic in India

Lupin Q1 FY2024 Results

Lupin Receives Approval from U.S. FDA for Fluocinolone Acetonide Topical Oil

Lupin Receives Approval from US FDA for Turqoz® (Norgestrel and Ethinyl Estradiol Tablets USP)

Lupin Foundation Strengthens Lives Program With Its First Mobile Medical Van ; Flag-Off by Health Minister, Government Of Rajasthan

Lupin Announces Resolution of USFDA Warning Letter for its Goa and Pithampur Facilities

1 2 … 21 22 23 … 102 103

Search

Hit enter to search or ESC to close